Macumira

Welcome to the home of Canada's first clinically proven and regulatory approved treatment for Dry Age-Related Macular Degeneration

  • With Macumira you can restore your vision and renew your life
  • Our treatment is safe, pain-free, and administered by your local eye-care professionals
  • Improve your vision with short and easy treatments
  • Book with your doctor or send them information on Macumira today

Welcome to MacuMira

Our pain free, non-invasive treatments are helping people with AMD see again
  • After the age of 45, 9% of the population will suffer from vision loss from Age-related Macular Degeneration.
  • Over time your vision gets worse and you lose the ability to work, drive, play sports, spend time with loved ones and do things on your own.
  • Treatments used included taking pills and eye injections to slow down the process.
  • Age-Related Macular Degeneration (AMD) is the leading cause of adult blindness.
  • Macumira is the first real option to stop and save your vision in Canada
  • We are a Safe, Easy, and Effective way to improve your vision

Overview

Age-related macular degeneration (AMD) Affects 2.3M Canadians

Dry AMD

  • 85-90% of AMD
  • Patients who suffer from this condition are advised to improve their lifestyle habits and take dietary supplements that may slow down the progression of the disease
  • Prescribed dietary supplements provide No recovery of lost visual acuity
  • Despite poor quality control and modest efficacy, over $2.5B of Eye Health Supplements sold Globally/yr

Wet AMD

  • 10-15% of AMD (more severe cases)
  • Most people with Wet AMD have progressed over time from Dry AMD
  • Treated by intraocular injections every 4-6 weeks for rest of the patient’s life only to “slow down the progress” (not a cure)
  • Annual cost of injections in US/Canada varies depending on Plans/Coverage $1,200-$3,000/treatment

Solution

Non-invasive eyelid surface neurostimulation
  • Administered in Eyecare Clinics
  • Easy, Safe & Effective
  • Immediate visual improvement
  • Treatment Protocol:
  • Loading Phase: 4x Week 1
  • Maintenance: 1x every 2-3 months

Register here for more information

Interested in learning more about Technology updates? New Clinical Trials and expanding indications, Community Insights, Patient Testimonials?

1-866-248-0912

How it Works

Our process is easy and sustainable. Macumira can change your life

Macumira focuses on client comfort and sustainability. You know that your vision therapy is administered by certified professionals, the results are immediate. The therapy requires one appointment every 2-3 months and is affordable. Furthermore, scheduling appointments is easy and hassle free.

01.

Micro current

Painlessly delivered across closed eyelids with no injections, systemic drugs, or adverse side effects.

02.

Patented waveform

Developed to maximize efficacy while leaving the delicate structures of the eye undamaged.

03.

Patented delivery system

That is simple to use and easily administered by a certified Eyecare Practitioner or Ophthalmic Technician.

04.

Immediate results

And optimal visual improvement reached after initial treatment schedule of four 32 minute treatments over 10 days.

05.

Visual improvements

Maintained with 1x treatment every 2-3 months.

06.

Mechanism of Action

Stimulated Retinal Pigment Epithelium (RPE) cells enhanced Mitochondrial ATP formation leads to improved cellular function and clearing of drusen and other macular waste byproducts1.
Our clinically tested process will improve your vision, and can be maintained for the rest of your life with proper treatment.

Clinical Trial

60 patients enrolled in the trial with 40 in the treatment group and 20 in the placebo group

Treatment group:

  • 48%, of the patients improved by at least 10 letters on the EDTRS acuity chart
  • All patients in the treatment group showed improved vision
  • Improved by an average of 8.8 EDTRS letters along with a 25% average increase in EDTRS acuity with no adverse effects
  • Treated patients maintained their visual improvements for the duration of the trial

Placebo group:

  • Patient’s visual acuity down by 2% on average

Future Trials & Studies: Protocols and applications underway to study expanded Indications for Diabetic Retinopathy, DME, Wet AMD, Geographic Atrophy.

Testimonials

Revolutionary results with passionate patient reviews.
“I can see the streetsigns when I drivenow, they are much clearer and brighter”
– Patient
“I can see the clock on the wall and tell time again, I can sew again which I have not done in years. This has been life-changing”
– Patient
“I can get my drivers license again!!!”
– Patient

Resources for Patients & Caregivers